First-in-class drug approvals
RecordSTO-V2PVD0MBZF-95WVXXN20D-WVCP41
China · 2022
First-in-class drug approvals in China were 21 in 2022 (NMPA).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- NMPA
- Authority tier
- T1 Official
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
The number was the highest in the past five years, compared with 40 in 2023 and 21 in 2022.
Checked: the figure 21is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Medical Products Administration. (2022). Measures facilitate approval of 48 first-in-class innovative drugs. Retrieved September 17, 2026, from https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Via StatOrigin, https://statorigin.org/stat/stat_V2PVD0MBZF95WVXXN20DWVCP41
Other formats: MLA, Chicago, BibTeX
- MLA
- National Medical Products Administration. "Measures facilitate approval of 48 first-in-class innovative drugs." 2022, https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_V2PVD0MBZF95WVXXN20DWVCP41.
- Chicago
- National Medical Products Administration. "Measures facilitate approval of 48 first-in-class innovative drugs." 2022. https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_V2PVD0MBZF95WVXXN20DWVCP41.
- BibTeX
- @misc{nmpa2022firstwvcp41, author = {{National Medical Products Administration}}, title = {Measures facilitate approval of 48 first-in-class innovative drugs}, year = {2022}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_V2PVD0MBZF95WVXXN20DWVCP41}, note = {Original source: https://english.nmpa.gov.cn/2025-03/21/c\_1080286.htm. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Medical Products Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Measures facilitate approval of 48 first-in-class innovative drugs
- Type
- Press release
- Published
- —
- Locator
- Measures facilitate approval of 48 first-in-class innovative drugs
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_V2PVD0MBZF95WVXXN20DWVCP41